Novo Nordisk CEO set to defend Ozempic, Wegovy prices on Capitol Hill
The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.
Walmart’s stock was headed back into record territory on Tuesday, as Truist turned bullish on the discount retailer amid accelerating...
Even this top-performing pension plan has found it hard to beat low-fee passive investments.
Levi Strauss & Co.’s goal of generating $9 billion to $10 billion in annual revenue by 2027 will be pushed...
TikTok Music failed to renegotiate its contract with Universal Music Group following a prolonged clash between the two companies
“While it has not been my baseline outlook, I cannot rule out the risks that progress on inflation could continue...
Case-Shiller 20-city home price index rose 5.9% year-on-year in July.
Average Rating